Analgesics (Pharmacies) - Cuba

  • Cuba
  • Revenue in the Analgesics market is projected to reach US$25.21m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.54%, resulting in a market volume of US$30.00m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.26 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Cuba is experiencing steady growth and development, driven by various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Cuban consumers have shown a growing preference for analgesics purchased from pharmacies. This can be attributed to the trust and reliability associated with these establishments, as pharmacies are known for providing quality products and professional advice. Additionally, the convenience of accessing analgesics at pharmacies, which are often located in close proximity to residential areas, has contributed to the increasing demand.

Trends in the market:
One notable trend in the Cuban Analgesics (Pharmacies) market is the rising popularity of over-the-counter (OTC) analgesics. Consumers are increasingly opting for OTC products due to their ease of accessibility and affordability compared to prescription-based alternatives. This trend is driven by a growing awareness of self-care and a desire for immediate relief from common ailments such as headaches and muscle pain. Another trend in the market is the introduction of innovative analgesic products. Pharmaceutical companies are constantly developing new formulations and delivery methods to cater to evolving consumer needs. These innovations include extended-release tablets, topical creams, and fast-acting pain relievers. The availability of these advanced products in Cuban pharmacies has contributed to the overall growth of the market.

Local special circumstances:
Cuba has a unique healthcare system that heavily relies on pharmacies to provide essential medications to the population. Pharmacies play a crucial role in ensuring the availability of analgesics and other pharmaceutical products to meet the healthcare needs of the Cuban people. This reliance on pharmacies has created a favorable environment for the growth of the Analgesics (Pharmacies) market.

Underlying macroeconomic factors:
The Cuban economy has been experiencing gradual liberalization, leading to increased consumer purchasing power. As disposable incomes rise, consumers are more willing to spend on healthcare products, including analgesics. This economic growth, coupled with an aging population and a higher prevalence of chronic diseases, has contributed to the expansion of the Analgesics (Pharmacies) market in Cuba. In conclusion, the Analgesics (Pharmacies) market in Cuba is developing due to customer preferences for pharmacy-sourced products, trends such as the popularity of OTC analgesics and innovative formulations, local special circumstances that rely on pharmacies for healthcare access, and underlying macroeconomic factors including economic growth and changing demographics. This market is expected to continue growing as the demand for analgesics remains strong in Cuba.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)